MWM
CELG

Mascoma Wealth Management’s Celgene Corp CELG Stock Holding History

Mascoma Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10
Closed -$1K – 386
2019
Q2 		$1K Hold
10
– – ﹤0.01% 376
2019
Q1 		$1K Buy
+10
New +$875 ﹤0.01% 388
2017
Q3 		– Sell
-300
Closed -$39K – 437
2017
Q2 		$39K Hold
300
– – 0.03% 176
2017
Q1 		$37K Hold
300
– – 0.03% 167
2016
Q4 		$35K Buy
+300
New +$33.4K 0.03% 170

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HBK Investments
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Mascoma Wealth Management's CELG Position: Q3 2019 in Review

Mascoma Wealth Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 10 shares — an estimated $1K sold.

Mascoma Wealth Management first reported a position in CELG in Q4 2016 and held it in 5 quarters. The position peaked at $39K in Q2 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Mascoma Wealth Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Mascoma Wealth Management sold 10 Celgene Corp shares in Q3 2019, an estimated $1K.
  • Mascoma Wealth Management first reported a position in Celgene Corp in Q4 2016 and held it in 5 quarters.
  • Mascoma Wealth Management's Celgene Corp position peaked at $39K in Q2 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Mascoma Wealth Management's 13F filing for Q3 2019, filed 21 Nov 2019.